Econocom Group SE (EBR:ECONB)

CTI BioPharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	305	320	458	529	687	522
Market Cap Growth	-11.07%	-30.17%	-13.46%	-23.04%	31.57%	-3.22%
Enterprise Value	603	627	899	935	1,040	962
Last Close Price	1.83	1.79	2.32	2.45	3.01	1.98
PE Ratio	7.73	8.46	7.21	8.29	10.48	11.16
Forward PE	4.15	4.38	5.23	5.77	10.09	8.28
PS Ratio	0.11	0.12	0.17	0.20	0.29	0.21
PB Ratio	0.68	0.67	0.97	1.16	1.57	1.11
P/FCF Ratio	3.23	2.03	64.48	4.86	22.03	2.44
P/OCF Ratio	2.78	1.83	15.21	4.17	14.35	2.27
EV/Sales Ratio	0.21	0.23	0.34	0.36	0.44	0.38
EV/EBITDA Ratio	4.65	5.66	7.83	8.73	8.24	7.38
EV/EBIT Ratio	6.42	6.76	8.95	9.84	9.27	8.18
EV/FCF Ratio	6.38	3.97	126.58	8.60	33.34	4.49
Debt / Equity Ratio	1.37	1.02	0.98	1.33	1.21	1.45
Debt / EBITDA Ratio	4.76	3.66	3.44	4.80	3.64	4.51
Debt / FCF Ratio	6.55	3.05	65.28	5.59	17.03	3.21
Asset Turnover	1.22	1.17	1.10	1.07	0.95	0.90
Inventory Turnover	28.80	30.80	25.84	20.55	21.03	32.78
Quick Ratio	0.96	0.84	0.77	0.85	0.86	0.95
Current Ratio	1.25	1.08	1.11	1.06	1.07	1.10
Return on Equity (ROE)	8.72%	8.12%	12.52%	11.01%	15.25%	10.51%
Return on Assets (ROA)	2.53%	2.46%	2.60%	2.46%	2.81%	2.63%
Return on Capital (ROIC)	5.77%	6.13%	6.28%	5.84%	6.59%	5.77%
Return on Capital Employed (ROCE)	8.20%	9.60%	10.10%	9.80%	12.00%	11.40%
Earnings Yield	5.02%	11.82%	13.87%	12.06%	9.54%	8.96%
FCF Yield	30.95%	49.36%	1.55%	20.57%	4.54%	41.00%
Dividend Yield	5.43%	5.59%	6.89%	6.52%	4.65%	6.07%
Buyback Yield / Dilution	4.35%	4.04%	11.44%	6.89%	10.37%	5.02%
Total Shareholder Return	9.78%	9.63%	18.32%	13.41%	15.01%	11.09%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.